4:00 PM – 4:09 PM
Intra-hepatic cholangiocarcinoma: systemic therapy plus Y90 versus systemic therapy alone
4:09 PM – 4:18 PM
2.5 cm HCC without vascular invasion in patient with portal hypertension- Radiation Segmentectomy vs Ablation
4:18 PM – 4:28 PM
3 cm HCC in Patient without Hypertension - Ablation vs SBRT vs Surgery
4:28 PM – 4:37 PM
Intermediate Risk BCLC B Multifocal HCC: TACE vs TARE
4:37 PM – 4:46 PM
Multifocal advanced HCC with vascular invasion: Systemic therapy vs systemic therapy plus locoregional therapy
4:46 PM – 4:55 PM
Large HCC with VP2 invasion - SBRT vs. Y90
4:55 PM – 5:04 PM
Neuroendocrine Metastases: PRRT vs Locoregional Therapies
5:04 PM – 5:13 PM
Lung Metastases: Locoregional Therapy vs External Beam Radiation
5:13 PM – 5:22 PM
Painful Spinal Metastases: Locoregional Therapy vs Radiation
5:22 PM – 5:31 PM
Bilobar colorectal cancer hepatic metastatic disease: Y90 vs HAI pump
5:31 PM – 5:40 PM
Solitary 3 cm Colorectal Cancer Liver Metastasis in nonsurgical patient: External Beam Radiation vs Ablation
5:40 PM – 5:49 PM
T1A Renal cell carcinoma: ablation vs resection
5:49 PM – 6:00 PM
Discussion and Audience Q&A